» Authors » Tamara Iglesias

Tamara Iglesias

Explore the profile of Tamara Iglesias including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 112
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meny P, Iglesias T, Menendez C, Quintero J, Rios C, Ashfield N, et al.
Zoonoses Public Health . 2022 Mar; 69(5):526-536. PMID: 35347868
To investigate seroprevalence of anti-Leptospira antibodies in equines and associated workers in Uruguay, 891 equine and 150 human sera were drawn; 212 equine urine samples were also taken for culture....
2.
Mareque M, Montesinos P, Font P, Guinea J, De La Fuente A, Soto J, et al.
Clinicoecon Outcomes Res . 2021 Apr; 13:263-277. PMID: 33911887
Objective: To assess the incremental cost-utility ratio (ICUR) of gemtuzumab ozogamicin (GO) + standard of care (SOC) vs SOC alone for treatment of patients with AML from a Spanish Health...
3.
Gotarkar D, Longkumer T, Yamamoto N, Nanda A, Iglesias T, Li L, et al.
Physiol Plant . 2021 Mar; 172(4):1853-1866. PMID: 33749847
Drought stress in plants causes differential expression of numerous genes. One of these differentially expressed genes in rice is a specific amidohydrolase. We characterized this amidohydrolase gene on the rice...
4.
Rius N, Lung M, Fernandez-San Jose C, Iglesias T, Esperalba J, Moraga-Llop F, et al.
An Pediatr (Engl Ed) . 2021 Jan; 94(3):201. PMID: 33390356
No abstract available.
5.
Rius N, Lung M, Fernandez-San Jose C, Iglesias T, Esperalba J, Moraga-Llop F, et al.
An Pediatr (Engl Ed) . 2020 Aug; 93(6):396-402. PMID: 32741733
Introduction: The incidence of serogroup C invasive meningococcal disease (IMD) has decreased since the introduction of systematic vaccination in 2000. The aim of this study is to determine the number...
6.
Meny P, Menendez C, Ashfield N, Quintero J, Rios C, Iglesias T, et al.
Rev Argent Microbiol . 2019 Apr; 51(4):324-333. PMID: 30979517
Leptospirosis is important in Uruguay due to the economic loss caused by the diseases of production animals, mainly bovines, and also due to frequent human infection. We decided to study...
7.
Llopiz D, Ruiz M, Villanueva L, Iglesias T, Silva L, Egea J, et al.
Cancer Immunol Immunother . 2018 Dec; 68(3):379-393. PMID: 30547218
Immune checkpoint inhibitors are currently tested in different combinations in patients with advanced hepatocellular carcinoma (HCC). Nivolumab, an anti-PD-1 agent, has gained approval in the second-line setting in the USA....
8.
Villanueva L, Silva L, Llopiz D, Ruiz M, Iglesias T, Lozano T, et al.
Oncoimmunology . 2018 Apr; 7(4):e1409321. PMID: 29632721
Tumor infiltrating lymphocytes have been associated with a better prognostic and with higher response rates in patients treated with checkpoint inhibiting antibodies, suggesting that strategies promoting tumor inflammation may enhance...
9.
Iglesias T, Espina M, Montes-Bayon M, Sierra L, Blanco-Gonzalez E
Anal Bioanal Chem . 2014 Aug; 407(9):2423-31. PMID: 25142048
Epigenetic alterations are increasingly implicated in the initiation and progression of cancer. Genome-wide (global) hypomethylation seems to occur in early neoplasia and is a feature of genomic DNA derived from...